Merck & Co., Inc. is 196.1x more valuable than Tyra Biosciences, Inc. by market capitalization ($298.26 B vs $1.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TYRA | MRK |
|---|---|---|
| Market cap | $1.52 B | $298.26 B |
| US-listed rank | #2327 | #45 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | -$119.95M | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.3 |
| SEC filings | 396 | 996 |
Merck & Co., Inc. is 196.1x more valuable than Tyra Biosciences, Inc. by market capitalization ($298.26 B vs $1.52 B).
Full pages: Tyra Biosciences, Inc. and Merck & Co., Inc., or browse the full rankings.